Lunit SCOPE IO
AI analysis of tumor microenvironment features from H&E slides for biopharma research.
- Tool type
- AI tumor microenvironment analysis software
- Made for
- Biopharma R&D and biomarker teams
- Runs on
- Digital pathology platforms and CRO partner systems
- Lunit states deployment across digital pathology platforms and CRO partners with broad scanner and file-type compatibility; specific runtimes are not named.
What it does
Lunit SCOPE IO analyzes H&E-stained tumor slide images, including whole-slide images, and produces quantitative tumor microenvironment readouts. It extracts morphological features such as tumor-stroma borders, necrosis, mitosis, and tumor-stroma ratio, identifies cell types including tumor cells, lymphocytes, macrophages, fibroblasts, and endothelial cells, and classifies immune phenotypes as Inflamed, Excluded, or Desert.
Biopharma teams use it to identify tumor-agnostic, H&E-based immune biomarker candidates, enrich immunotherapy trials, and support companion diagnostic development without additional stains or assays. Lunit describes it as built for end-to-end CDx development, with broad scanner and file-type compatibility and scalable deployment across digital pathology platforms and CRO partners.
The product is aimed at biopharma research and drug development teams. It is labeled Research Use Only and is not for use in diagnostic procedures or decisions. Access begins by scheduling a demo with Lunit, and pricing or licensing terms are not published on the product page, so buyers should confirm costs and validation details with Lunit representatives.
What it can do
- Extracts morphological features from H&E slides, including TLS, necrosis, mitosis, tumor-stroma ratio, and tumor-stroma borders
- Identifies cell types such as tumor cells, lymphocytes, macrophages, fibroblasts, and endothelial cells
- Analyzes TILs and classifies immune phenotypes (Inflamed, Excluded, Desert)
- Supports H&E-based CDx development from biomarker discovery through immunotherapy response prediction
- Quantifies how tumor microenvironment cellular composition correlates with treatment response
Before you choose
- Labeled Research Use Only; not for diagnostic procedures or decisions.
- Pricing and purchase terms are not listed on the product page; confirm cost with Lunit.
- Detailed validation results are available from Lunit representatives.
Listed under
Get started
Demo request is the stated entry point.
- Request a demo through the 'Schedule a Demo' link on the product page.
- Confirm compatibility of your scanner and file types with Lunit's team.
- Plan deployment across your digital pathology platform or CRO partner setup with Lunit representatives.
Plans and prices
Pricing and billing terms must be confirmed with Lunit.
We couldn’t find published prices for Lunit SCOPE IO.
Sources for this overview
Product pages, documentation, and pricing checked 29 Oct 2026. Each source supports part of the overview; availability and prices can change.
- AI-Powered TME Analysis Software | Lunit ↗www.lunit.io
- Early Detection & Precision Oncology Medical AI Software | Lunit ↗www.lunit.io
- Product Documentation ↗www.lunit.io
Ratings and reviews
No ratings for Lunit SCOPE IO yet.
What’s changed
Free accountSignals
Free accountData and security
Free accountCompare with similar tools
Free accountWhere this comes from
How we research- Company website
- lunit.io: product, pricing and policy pages
- Social accounts
- Accounts the company links, and its posts on X
- Human review
- Checked by a person
- knowledge_base
- manual_review
Last checked 29 Oct 2026. Every field keeps its source and date; unknown means we couldn’t confirm it.